Global Clostridium Difficile Infections Market Expected to Reach $1.5 Billion by 2024; Finds New Report
The global therapeutics and prophylactics market for Clostridium difficile infections (CDIs) will expand more than fourfold from $356.3 million in 2014 to over $1.5 billion by 2024, representing an impressive Compound Annual Growth Rate (CAGR) of 15.8%, according to new research.
View full press release